RxDoctor Payments DataLook up a doctor →

Sabry Ayad, MD

Anesthesiology · Cleveland, OHNPI 1649271800

Payments from drug & device makers

$850,919in general payments, 2019–2025

Across 711 payments — averaging $1196.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$202K
  • Pacira Pharmaceuticals Incorporated$175K
  • Acelrx Pharmaceuticals, Inc.$147K
  • Heron Therapeutics, Inc.$79K
  • Vertex$54K
  • Covidien LP$42K
  • plus $152K from 29 others
$25,078in research payments, 2019–2025

Across 11 payments — averaging $2279.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Trevena, Inc.$23K
  • Takeda Pharmaceuticals U.S.A., Inc.$2K
  • US Endoscopy$500

What the payments were for

  • Consulting fees$90,93621%
  • Speaking & faculty fees$257,23460%
  • Travel & lodging$65,69715%
  • Food & beverage$13,1433%
  • Education$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$850,919 in reported general payments places this provider in the 95th percentile of 1,623 anesthesiology providers in Ohio.

See all anesthesiology providers in Ohio

Medicare billing

Part B allowed, 2024
$15,054
Medicare patients
100
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →